- | Country : -
- | organs : -
- | Specialty : -
The purpose of this study is to determine the safety and tolerability of rebastinib when combined with antitubulin therapy with paclitaxel or eribulin in patients with advanced breast cancer.
- Breast Cancer,Breast Adenocarcinoma,Human Epidermal Growth Factor 2 Negative Carcinoma of Breast,Recurrent Breast Carcinoma,Stage IV Breast Cancer